Vivitrol for alcohol-use disorder
Monthly injectable naltrexone may be an option for some patients after medical review and benefits verification.
Alcohol use disorder treatment can begin with a discussion about drinking, health, control over use and what you want to change. Medication, behavioral treatment and recovery support may help. The first decision is whether reducing or stopping alcohol requires medically supervised withdrawal care. A relapse-prevention medicine does not make it safe to manage dangerous withdrawal at home.
The main approved medication options work differently. Naltrexone blocks opioid receptors and can help reduce heavy drinking or support an agreed alcohol goal; the injection has its own abstinence-before-start requirements. Acamprosate supports maintaining abstinence after alcohol has stopped and withdrawal has been addressed. Disulfiram creates a potentially serious reaction with alcohol and is chosen with informed consent for an abstinence-oriented plan. None prevents intoxication or alcohol poisoning.
The clinician assesses drinking frequency, amount, loss of control, consequences, current symptoms and previous attempts to stop. Prior seizures or delirium during withdrawal are especially important. Kidney and liver function, opioid exposure, pregnancy, psychiatric symptoms and daily medication routines can affect selection. Being able to work or maintain responsibilities does not rule out an alcohol-use problem.
Describe your last drink, usual pattern, previous withdrawal and any current shaking, sweating, nausea, confusion or hallucinations. The clinician decides whether outpatient treatment is suitable or whether more monitored care is needed. This decision should come before a plan to stop drinking suddenly.
Discuss whether your goal is abstinence, reducing harm or another clinically appropriate change. Review naltrexone’s opioid and liver precautions, acamprosate’s kidney requirements and daily tablet burden, and disulfiram’s alcohol-reaction and consent requirements. A medicine is chosen for safety and fit, not because it appears first on a list.
Behavioral treatment can address stress, sleep, relationships and situations linked to drinking. Mental-health and other substance-use treatment may need coordination. Decide which support you want and what is actually available, whether individual therapy, recovery support or another program.
Agree on how progress will be measured: drinking, urges, health, daily function and side effects. Clarify laboratory monitoring, refill or injection visits and whom to contact if drinking returns. A lapse is information for reassessment and does not make continued care pointless.
Bring a medication list, alcohol-use history, recent laboratory results and records of withdrawal or rehab care. Include opioid pain medicines, tramadol, methadone, buprenorphine and nonprescribed substances. If stopping alcohol has caused symptoms before, tell the team when arranging the evaluation. Do not arrive after an unsupervised detox solely to meet a medicine’s starting requirement.
Call 911 or seek emergency care for a seizure, severe confusion, hallucinations with worsening withdrawal, collapse or inability to remain safe. Alcohol mixed with opioids or sedatives can cause dangerous breathing problems. Relapse-prevention medicines have separate adverse-effect precautions and may not be suitable for everyone. Symptoms of liver injury, serious medication reactions or severe dehydration need prompt review.
Treatment review should cover actual drinking, cravings, sleep, mood, adherence and tolerability. If urges continue, check whether the medicine was taken, whether the selected treatment fits the goal and whether additional support is needed. Some people benefit from ongoing medication; duration should be based on benefit and preference rather than a promised cure date. Stopping or changing medicines needs a continuity plan.
Ask whether the service provides AUD evaluation, medication management, behavioral treatment and referrals for withdrawal care. Confirm the costs of visits, tests and medication separately. Injection coverage may differ from oral treatment. Ask for the actual outpatient care intensity and schedule, and whether withdrawal assessment or referral is part of the service.
Call 911 or seek emergency care for a seizure, severe confusion, hallucinations with worsening withdrawal, collapse or inability to remain safe. Alcohol mixed with opioids or sedatives can cause dangerous breathing problems. Relapse-prevention medicines have separate adverse-effect precautions and may not be suitable for everyone. Symptoms of liver injury, serious medication reactions or severe dehydration need prompt review.
Describe your last drink, usual pattern, previous withdrawal and any current shaking, sweating, nausea, confusion or hallucinations. The clinician decides whether outpatient treatment is suitable or whether more monitored care is needed. This decision should come before a plan to stop drinking suddenly.
Discuss whether your goal is abstinence, reducing harm or another clinically appropriate change. Review naltrexone’s opioid and liver precautions, acamprosate’s kidney requirements and daily tablet burden, and disulfiram’s alcohol-reaction and consent requirements. A medicine is chosen for safety and fit, not because it appears first on a list.
Behavioral treatment can address stress, sleep, relationships and situations linked to drinking. Mental-health and other substance-use treatment may need coordination. Decide which support you want and what is actually available, whether individual therapy, recovery support or another program.
Agree on how progress will be measured: drinking, urges, health, daily function and side effects. Clarify laboratory monitoring, refill or injection visits and whom to contact if drinking returns. A lapse is information for reassessment and does not make continued care pointless.
Vivitrol is a monthly injection of naltrexone. It is used for alcohol dependence in patients able to abstain before starting, and to prevent relapse to opioid dependence after detoxification. Those are different starting situations. The evaluation needs to establish which condition is being treated, whether withdrawal has been safely addressed and whether a month-long opioid blocker fits your health and pain-treatment needs.
Naltrexone blocks opioid receptors. For alcohol treatment, it can reduce alcohol-related reward and support a recovery plan. For opioid treatment, it blocks opioid effects. It does not relieve opioid withdrawal or treat dangerous alcohol withdrawal. Unlike buprenorphine, it is not an opioid agonist. It also does not protect someone who drinks from intoxication, impaired driving or alcohol poisoning.
For alcohol dependence, the first injection is for a patient who can abstain in an outpatient setting and is not actively drinking at administration. Every patient needs an opioid exposure review, even when alcohol is the reason for treatment. Pain medicines, tramadol, methadone, buprenorphine and opioid-containing cough or diarrhea remedies matter. Current opioid dependence, acute opioid withdrawal, a positive opioid urine screen or a failed naloxone challenge are label contraindications. Liver history and pregnancy require individual review.
Alcohol withdrawal can cause seizures, delirium and other life-threatening problems. The clinician assesses current symptoms, previous severe withdrawal, last use, other medicines and the support/monitoring available before selecting outpatient or hospital-level care. Confirm with addiction-care intake whether supervised withdrawal assessment and a monitored treatment setting can be arranged. An addiction appointment or craving medicine does not establish that capability. Call 911 for a seizure, severe confusion, collapse or breathing trouble during withdrawal. Other severe or worsening withdrawal symptoms need emergency department care now. Do not wait for a routine booking.
Have your insurance card ready when booking. Share member details through the clinic’s confirmed secure intake process. Check with the clinic and your insurer that the exact plan covers the clinician and requested service. Ask about visit charges, any separately billed tests or medicines, and any referral or authorization requirement. Coverage and your copay or deductible depend on the plan; request a written estimate if paying yourself.
An injection does not guarantee elimination of urges. Discuss their timing, drinking, triggers and other symptoms. The clinician can review treatment fit and support without assuming that an extra or early injection is appropriate.
No. The answer depends on the diagnosis, severity, tests and the medicine. Naltrexone and disulfiram require careful liver review, while acamprosate has important kidney restrictions. Do not select or rule out a medicine from one general rule.
Alcohol use disorder is a medical condition in which drinking becomes difficult to control and causes harm or distress. The term alcoholism is often used for a severe alcohol problem, but clinicians use alcohol use disorder to describe a range from mild to severe. A diagnosis considers symptoms over the past 12 months, rather than a label or the amount consumed on one occasion. Treatment can include behavioral support and medication.
- Drinking more or longer than intended. - Being unable to cut down. - Spending substantial time drinking or recovering. - Having strong urges to drink. - Missing responsibilities. - Continuing despite relationship problems. - Giving up valued activities. - Drinking in dangerous situations. - Continuing despite health problems. - Needing more alcohol for the same effect. - Having withdrawal.
Two or more criteria can support an AUD diagnosis after clinical assessment. Withdrawal can be dangerous; do not abruptly stop heavy drinking without medical advice.
A screening questionnaire can help you recognize concerns, but it does not replace a clinical assessment. Describe your drinking, attempts to cut down, effects on daily life and withdrawal history. A clinician can assess the symptoms and recommend treatment. Do not rely on a quiz to assess withdrawal. If stopping or cutting down causes shaking or other withdrawal symptoms, contact a clinician right away. If withdrawal causes severe confusion, hallucinations or a seizure, call 911 for emergency assessment.
Monthly injectable naltrexone may be an option for some patients after medical review and benefits verification.
Counseling can help with triggers, stress, family pressure, routines, co-occurring mental-health symptoms, and relapse-prevention planning.
Medication continuity and follow-up planning matter after detox, inpatient rehab, residential treatment, or intensive outpatient care.
Coverage review can include the visit, counseling, testing, medication, and pharmacy or specialty-medication requirements.
Bronx
932 E 174th St, Bronx, NY 10460
A Bronx location for opioid addiction treatment, same-day evaluation when available, and practical medication follow-up.
View local MAT details Get directionsQueens
37-15 23rd Ave, Astoria, NY 11105
A western Queens location for opioid addiction treatment, buprenorphine follow-up, and realistic neighborhood access.
View local MAT details Get directions
Bronx
2063A Bartow Ave, Bronx, NY 10475
A Bronx option for opioid use disorder care, bridge-review visits, and practical next-step coordination.
View local MAT details Get directions
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
A central Brooklyn location for medication for addiction treatment, follow-up planning, and local access that is easier to keep using.
View local MAT details Get directions
Long Island
232 W Old Country Rd, Hicksville, NY 11801
A Long Island location for opioid addiction treatment, medication follow-up, and insurance-supported recovery care.
View local MAT details Get directions
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
A central Queens clinic for timely addiction medicine evaluation, Suboxone follow-up, and practical neighborhood access.
View local MAT details Get directions
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
A southeast Queens location for opioid use disorder care, bridge review, and clear follow-up planning.
View local MAT details Get directions
Queens
30-07 36th Ave, Astoria, NY 11106
A workday-friendly Queens location for medication treatment, monitoring, and repeat follow-up visits.
View local MAT details Get directions
Long Island
135 Mineola Blvd, Mineola, NY 11501
A core Long Island location for opioid addiction treatment, insurance review, and reliable ongoing follow-up.
View local MAT details Get directions
Manhattan
259 1st Ave, New York, NY 10003
A Manhattan location for addiction medicine visits, medication follow-up, and structured treatment planning.
View local MAT details Get directions
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
A Brooklyn location for medication for addiction treatment, same-day access review, and practical ongoing care.
View local MAT details Get directionsFind addiction treatment in NYC and Long Island with Nao Medical, including outpatient addiction care, opioid treatment, alcohol support, counseling, medication options, insurance, Medicaid, and telemedicine.
Find gambling addiction treatment and counseling support in NYC with Nao Medical, including confidential assessment, insurance review, Medicaid questions, and referral coordination when needed.
Book tobacco cessation treatment in NYC and Long Island with Nao Medical. Review nicotine dependence, quit planning, medication options, counseling, insurance, and follow-up.
Review court-mandated addiction treatment, probation-related care, documentation, drug testing, MAT, counseling, and insurance pathways with Nao Medical in NYC.
Continue addiction treatment after detox, inpatient rehab, residential care, or IOP with Nao Medical outpatient follow-up, MAT, counseling, insurance, and Medicaid support.
Review Medicaid addiction treatment options in NYC and Long Island with Nao Medical, including Suboxone, MAT, alcohol care, counseling, drug testing, and telemedicine.
Find addiction counseling in NYC and Long Island with Nao Medical, including individual therapy, group therapy planning, CASAC-informed support, MAT coordination, and insurance review.
Find older adult addiction treatment in NYC and Long Island with Nao Medical, including medication review, alcohol and opioid care, counseling, insurance, Medicare, and family support.
Find young adult substance use treatment in NYC and Long Island with Nao Medical, including confidential assessment, family guidance, counseling, MAT review, insurance, and telemedicine.
Private addiction medicine across the Bronx, Brooklyn, Queens, and Manhattan, with MAT, alcohol support, counseling, Medicaid review, court-related documentation review, and telemedicine backup when appropriate.
Bronx addiction medicine access for opioid treatment, alcohol-use concerns, counseling coordination, Medicaid review, court-related needs, and local follow-up.
Brooklyn addiction treatment access for Suboxone and MAT, alcohol-use review, counseling coordination, court-related documentation review, and post-rehab outpatient follow-up.
Queens addiction medicine access in Astoria, Jackson Heights, Jamaica, and Long Island City, with opioid treatment, alcohol support, counseling coordination, Medicaid review, and telemedicine options.
Manhattan addiction medicine through StuyTown, with private medication review, counseling coordination, insurance and Medicaid questions, and virtual follow-up when clinically appropriate.
Long Island addiction treatment access in Hicksville and Mineola, including outpatient addiction care routing, MAT, alcohol-use review, counseling coordination, Medicaid review, and post-rehab follow-up.
Fast evaluation for urgent but non-emergency medication, counseling, testing, safety, and follow-up questions.
Scheduled addiction care for medication, counseling, relapse prevention, testing, insurance, and local follow-up.
Virtual review for selected needs, with local backup when testing, injections, or physical assessment are needed.
Follow-up planning for triggers, cravings, medication gaps, discharge transitions, and higher-risk moments.
Coordinated review for addiction plus anxiety, depression, trauma, insomnia, ADHD, or other concerns.
Testing coordination for treatment monitoring, court instructions, employer requests, MAT, and documentation needs.
Review opioid, stimulant, cannabis, benzodiazepine, prescription medication, Kratom, and mixed-substance concerns.
Review cocaine, crack cocaine, methamphetamine, Adderall misuse, sleep, mood, testing, and relapse risk.
Review marijuana or THC use concerns, anxiety, sleep, school or work impact, and family support.
Review opioid pain pills, benzodiazepines, stimulants, sleep medications, withdrawal risk, and medication coordination.
Review naloxone access, family safety planning, opioid risk, fentanyl exposure, and follow-up care.
Review youth, family, school, privacy, consent, mental-health, and referral questions carefully.
Review substance use, safety, testing, documentation, treatment recommendations, insurance, and follow-up.
Review whether an OASAS-certified setting, specific credential, or written requirement may be needed.
Review court, attorney, probation, parole, agency, testing, and documentation requirements.
Review alcohol or drug-related driving requirements and what documentation or treatment may be needed.
Review medication continuity, counseling, cravings, relapse risk, and discharge instructions after detox.
Review Medicaid coverage for MAT visits, testing, counseling, medication, pharmacy benefits, and prior authorization.
Compare local outpatient addiction care access across NYC and Long Island.
Review outpatient addiction medicine when patients are comparing nearby rehab options.
Review scheduled outpatient addiction treatment, medication, counseling, testing, and follow-up.
Review urgent but non-emergency addiction medicine access and same-day limitations.
Review cost factors, insurance, Medicaid, medication, testing, and self-pay options.
Review privacy, self-pay, records release, employer, family, and third-party documentation questions.
Arrange an evaluation to discuss suitable care, preparation and follow-up with a clinician.
Nao Medical provides outpatient addiction care. The first visit can focus on the immediate clinical question and medication planning when relevant. When wanted or clinically recommended, the care plan can also include counseling, recovery support, and closer follow-up. Related information: outpatient addiction care.
Patients who want more support can add counseling, relapse-prevention work, care coordination, and recovery follow-up through the outpatient addiction program.
Coverage depends on your exact plan, clinician, location and service. Check participation and expected charges with the clinic and your insurer before booking. Review addiction-treatment insurance support
, relapse-prevention planning, and follow-up are available through Nao Medical's outpatient addiction care. Counseling
Compare alcohol-use-disorder medications, Vivitrol treatment, oral naltrexone, acamprosate, and disulfiram. Medication does not replace emergency care for dangerous alcohol withdrawal.
Content was updated August 2, 2026 from the cited sources and Nao Medical's current service information. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.